MetaCap

Beta Bionics (BBNX) vs Avita Medical (RCEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Avita Medical (RCEL) has outperformed Beta Bionics (BBNX) over the past year, gaining 312.1% versus a loss of 57.5%. Beta Bionics is the larger company by market cap ($726.3 million vs $495.0 million), about 1.5 times the size. Avita Medical converts more of its revenue into profit, with a net margin of -67.8% versus -73.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BBNX-57.48%RCEL+312.14%
+388%+147%-94%
Nov 21, 20251 yearNov 20, 2026
BBNX-43.89%RCEL+71.65%
+90%+10%-70%
Jan 27, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BBNX versus RCEL key metrics
MetricBBNXRCEL
Share price$13.36$15.62
Market cap$726.34M$494.96M
1-day change+0.30%-2.31%
YTD return-56.15%+352.75%
1-year return-57.48%+312.14%
5-year return—+10.78%
EPS (TTM)$-1.83$-1.17
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$100.25M$71.61M
Revenue growth (YoY)+53.94%+11.45%
Net income (latest FY)$-73.20M$-48.59M
Gross margin55.40%82.13%
Operating margin-71.50%-59.40%
Net margin-73.02%-67.85%
52-week high$32.71$18.43
52-week low$8.80$3.22
Distance from 52-week high-59.16%-15.25%
Analyst consensusbuystrong_buy
Avg. price target upside+87.87%+32.46%
Average volume1.21M417.02K
Shares outstanding54.37M31.69M
Employees420226
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RCEL has outperformed BBNX by 369.6 percentage points over the past year.
  • Avita Medical is more profitable, keeping -67.8 cents of every revenue dollar as net income versus -73.0 cents for Beta Bionics.
  • Beta Bionics grew revenue faster in its latest fiscal year (+53.94% vs +11.45%).

About Beta Bionics

BBNX stock →

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.

Health Care · Medical/Dental Instruments · 420 employees

About Avita Medical

RCEL stock →

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.

Health Care · Medical/Dental Instruments · 226 employees

BBNX vs RCEL FAQ

Which is bigger, Beta Bionics or Avita Medical?

Beta Bionics (BBNX) is larger, with a market capitalization of $726.34M compared with $494.96M for Avita Medical (RCEL).

Which stock has performed better over the past year, BBNX or RCEL?

RCEL returned +312.14% over the past 12 months, compared with -57.48% for BBNX (price return, excluding dividends). Past performance does not predict future results.

Are Beta Bionics and Avita Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons